• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT ANTI-HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT ANTI-HCV Back to Search Results
Catalog Number 06C37-27
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/17/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: (b)(6).All available patient information has been included.No additional patient details are available.This report is being filed on an international product, list number 6c37 that has a similar product distributed in the us, list number 1l79.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false nonreactive architect (b)(6) results on one patient.The following data was provided: sid (b)(6) initial = 0.35 s/co (nonreactive), repeated 1.67 and 1.85 s/co (reactive) (reference range greater than or equal to 1.00 = reactive).The patient historically tested positive (1.72 and 1.1 s/co).No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and in-house testing of the complaint lot number.Return testing was not completed as returns were not available.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any issues with the likely cause lot and complaint issue.A retained file reagent kit of the complaint lot was tested in a sensitivity setup and inhouse testing determined that the sensitivity performance of the lot was acceptable.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the architect anti-hcv reagent lot number 14465be00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HCV
Type of Device
ANTI-HCV
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10489226
MDR Text Key241306061
Report Number3002809144-2020-00884
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 09/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/03/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/03/2020
Device Catalogue Number06C37-27
Device Lot Number14465BE00
Was Device Available for Evaluation? No
Date Manufacturer Received09/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I1000SR ANALYZER, LIST 01L86-01,; ARCHITECT I1000SR ANALYZER, LIST 01L86-01,; SERIAL (B)(6); SERIAL (B)(6)
-
-